Zeskind Benjamin J.

Zeskind Benjamin J., PRESIDENT AND CEO, Director, accounts for 2 disclosed filings worth $3.4M, all concentrated in Immuneering Corp (IMRX), active 2026. The record is heavily weighted toward buying, with $10.9K in purchases against $0 in sales. The largest single open-market purchase on record is $10.9K in Immuneering Corp. Data is sourced from official SEC Form 3, 4, and 5 filings.